Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 25 % of short-term debt in 2024; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 3.6 to 1.8.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2024.
Financials
Financial year 2024
Apotheek Ravestijn from Brasschaat, company number BE0436005991, closed financial year 2024 with a result of € -4,758 after tax. For that financial year Apotheek Ravestijn recorded a gross margin of € 126,901 and equity of € 188,072. Compared with financial year 2023, the result moved from € 39,809 to € -4,758. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
€ 188,072
▼ 2% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -4,758
▼ still € 39,809 profit in 2023
Profit after tax over the fiscal year.
€ 25,270
▼ 39% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 126,072.
People and assets in 2024
1.8
▼ 1.5 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 74,294
▲ 1% vs 2023
€ 41,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 11,022
▼ 4% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 65,762
▼ 31% vs 2023
€ 30,857 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 57,394
▲ 71% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 11,443
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 157,435 | € 205,730 | € 167,390 | € 126,901 | ▼ 24% |
| Profit after taxes | € 42,225 | € 78,619 | € 39,809 | € -4,758 | ▼ € 44,566 |
| Equity | € 134,402 | € 163,021 | € 192,830 | € 188,072 | ▼ 2% |
| Total debts | € 352,639 | € 333,441 | € 266,499 | € 405,961 | ▲ 52% |
| Cash | € 33,540 | € 40,107 | € 41,509 | € 25,270 | ▼ 39% |
| Land & buildings | € 106,295 | € 85,807 | € 65,319 | € 44,830 | ▼ 31% |
| Retained profit | € 72,402 | € 101,021 | € 130,830 | € 126,072 | ▼ 4% |
| Dividend | € 0 | € 50,000 | € 10,000 | € 0 | ▼ 100% |
| Bank debt | € 154,567 | € 123,770 | € 95,367 | € 65,762 | ▼ 31% |
| Balance sheet total | € 487,041 | € 496,462 | € 459,329 | € 594,034 | ▲ 29% |
| Employees (FTE) | 2.2 | 3.6 | 3.3 | 1.8 | ▼ 1.5 |
Key figures of Apotheek Ravestijn, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Apotheek Ravestijn?
What happened at Apotheek Ravestijn in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Schippers-Ravestijn BV stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 4,758 (▼ € 44,566 vs 2023). filed late Source: NBB ↗
- Schippers-Ravestijn BV became a director. NBB
- New establishment in Brasschaat. KBO
- Start of the company according to the CBE. KBO
In short
From € 42,225 profit in 2021 to € 4,758 loss in 2024.
Paid € 15,752 in corporate taxes since 2021.
Best year ever: 2022, with € 78,619 profit.
On average € 70,500 of value added per employee in 2024.
Management
The stake of SCHIPPERS - RAVESTIJN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek RavestijnBehind Apotheek Ravestijn is Mark Schippers. The shares are held by SCHIPPERS - RAVESTIJN (100%).
Directors
According to the 2024 annual accounts
Mark Schippers
Director
Director · represented by An Ravestijn
since 2020 · until 2026
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Bredabaan 377
2930 Brasschaat
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0436.005.991
- VAT number
- BE 0436.005.991
- Registered office
- Bredabaan 377, 2930 Brasschaat
- Names & denominations
- Apotheek Ravestijn
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 7 December 1988
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- [email protected] 03/651.81.78
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten